To investigate whether HEMO is a marker of cancer progression, we stratified samples by tumor stage and grade, in the TCGA cohorts where the increase of HEMO expression in tumors was the highest compared to normal tissues (Fig. S2). The gene discussed is ERVMER34-1; the disease is neoplasm.